Pevita Pearce
In the modern healthcare landscape, the drive to reduce costs often leads to a dangerous paradox: the pursuit of "site-of-service" savings—shifting care to lower-cost facilities—without verifying the clinical accuracy of the diagnostic output. As Amy Cosler, Chief Growth & Partnerships Officer at Covera Health, succinctly puts it: "Site-of-service savings without measuring whether the results were actually right is cost deferral, not cost management."
This perspective sits at the heart of a shifting paradigm in medical imaging, where quality, consistency, and diagnostic precision are finally being prioritized over simple transactional efficiency.
The Main Facts: Challenging the Commodity Myth
For decades, the healthcare industry has largely treated radiology as a commodity—a "plug-and-play" service where a scan is a scan, regardless of where or by whom it is performed. Patients, payers, and even providers have often operated under the assumption that a diagnostic imaging procedure is akin to a blood test: standardized, repeatable, and universally interpreted.
However, Covera Health is spearheading a movement to dismantle this misconception. The reality of radiology is that it is highly variable. The quality of a scan depends on a multitude of factors, including the sophistication of the imaging equipment, the protocols used, and, most importantly, the clinical expertise of the radiologist interpreting the data.
When imaging is treated as a commodity, diagnostic errors—such as misinterpretations or missed findings—become inevitable. These errors trigger a cascade of downstream costs, including unnecessary biopsies, redundant testing, ineffective surgeries, and delayed treatments. Covera Health’s core thesis is that by applying data science and advanced analytics to imaging, healthcare stakeholders can ensure "right-first-time" care, thereby driving genuine cost management rather than temporary savings.
Chronology: The Evolution of Diagnostic Oversight
The path to integrating clinical intelligence into radiology has been marked by several pivotal stages:
- The Era of Fragmentation (1990s–2010): Diagnostic imaging saw rapid technological advancement, but oversight remained fragmented. The primary focus for insurers was "utilization management"—essentially ensuring patients didn’t get scans they didn’t need. Quality, however, was largely ignored.
- The Rise of Value-Based Care (2010–2018): As the U.S. healthcare system began shifting from fee-for-service to value-based models, payers began to realize that high-cost interventions were often the result of poor initial diagnostics. The conversation shifted toward "quality metrics."
- The Data Analytics Breakthrough (2018–2022): Companies like Covera Health began leveraging massive datasets to evaluate provider performance. Instead of relying on subjective peer reviews, firms started using algorithmic assessments to track diagnostic outcomes across large patient populations.
- The Current Landscape (2023–Present): We are currently in a phase where "Clinical Intelligence" is becoming a standard expectation for self-insured employers and health plans. The focus has moved beyond "How many scans?" to "How accurate were the results of these scans?"
Supporting Data: The Cost of Diagnostic Variance
The economic impact of diagnostic inconsistency is staggering. Data from across the healthcare sector suggests that diagnostic errors are among the leading causes of medical malpractice claims and avoidable medical spending.
- The "Downstream Cost" Multiplier: Research indicates that a single misdiagnosed imaging report can lead to between $5,000 and $20,000 in unnecessary follow-up care. When extrapolated across a large health plan, these costs reach into the billions annually.
- Provider Variability: Studies have shown that even within the same hospital system, the rate of "diagnostic yield"—the percentage of scans that lead to actionable clinical decisions—can vary by as much as 30% depending on the radiologist’s sub-specialty and experience.
- The Utilization Trap: Payers have spent years focusing on "Site of Service" (SOS) initiatives, moving imaging from high-cost hospital outpatient departments to lower-cost freestanding centers. However, data suggests that if the lower-cost center produces an inaccurate result, the cost savings are immediately eroded by the need for re-testing or incorrect treatment paths.
Official Responses and Strategic Vision
Amy Cosler’s leadership at Covera Health reflects a broader industry push toward "intelligent network design." By partnering with health plans, Covera creates a framework where patients are steered toward imaging centers that demonstrate higher consistency and diagnostic accuracy.
"We aren’t just looking at the price tag of an MRI," says Cosler. "We are looking at the clinical outcomes that follow that MRI. If a patient gets a high-quality scan at a slightly higher cost, but it prevents an unnecessary surgery, that is the definition of true cost management."
This approach requires deep integration with both payers and imaging centers. For payers, it offers a way to manage risk; for providers, it offers a feedback loop that allows them to refine their protocols and improve their standing within the network. This move away from "transactional healthcare" is increasingly becoming the gold standard for large self-insured employers looking to control their skyrocketing medical spend.
Implications: The Future of Precision Imaging
The implications of this shift are profound for the entire healthcare ecosystem.
1. The Death of the "Scan is a Scan" Mentality
As analytics become more granular, the industry will likely see a tiered network for radiology services. Much like "Centers of Excellence" for complex surgeries, we will likely see "Centers of Diagnostic Excellence" where imaging quality is certified by independent, data-driven entities.
2. Payer-Provider Collaboration
The adversarial relationship between payers and imaging centers—often defined by disputes over prior authorization—is slowly evolving into a collaborative effort centered on quality. When payers use data to reward high-quality imaging, providers are incentivized to invest in better training, better software, and better diagnostic workflows.
3. Patient Empowerment
As data becomes more transparent, patients will increasingly have access to "quality scores" for their diagnostic imaging centers. This will force a market correction, where lower-performing facilities must either improve their standards or lose their patient base.
4. Regulatory and Policy Shifts
Regulators are beginning to take note of diagnostic error rates. It is foreseeable that in the coming decade, reporting diagnostic quality metrics will become a mandate for participation in federal and state health programs, much like the reporting of surgical infection rates is today.
Conclusion: Toward Sustainable Care
The argument presented by Covera Health is not merely a business strategy; it is a clinical imperative. By challenging the industry to stop viewing radiology as a commodity, they are highlighting the uncomfortable truth that cost-cutting measures, when applied blindly, often exacerbate the very waste they seek to eliminate.
"Site-of-service savings," as Cosler warns, is a hollow victory if the clinical outcome is flawed. The future of healthcare will be built by those who recognize that the most expensive scan is the one that provides the wrong answer. By shifting the focus to clinical intelligence, the industry can finally achieve the "triple aim": better outcomes, lower costs, and a more sustainable healthcare system for all stakeholders.
As we move forward, the metric of success will no longer be how little we spend on a procedure, but how much value that procedure provides in the patient’s journey toward health. That is the essence of precision medicine, and it starts with the image.
Rifan Muazin
Siti Muinah
